Aprameya EngineeringNSE:APRAMEYA -0.41%42 Return-on-Tangible-Equity is 7.64% as of Mar. 2026, which is 64% below its 10-year median of 21.28. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 42/100. The stock has 6 warning signs investors should review. Among 757 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 59.18% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aprameya Engineering's annualized net income for the quarter that ended in Mar. 2026 was ₹51.0 Mil. Aprameya Engineering's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹667.9 Mil. Therefore, Aprameya Engineering's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 7.64%.
The historical rank and industry rank for Aprameya Engineering's Return-on-Tangible-Equity or its related term are showing as below:
NSE:APRAMEYA'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.64 Med: 21.28 Max: 176.15
Current: 7.64
During the past 7 years, Aprameya Engineering's highest Return-on-Tangible-Equity was 176.15%. The lowest was 7.64%. And the median was 21.28%.
NSE:APRAMEYA's Return-on-Tangible-Equity is ranked better than 59.18% of 757
companies
in the Medical Devices & Instruments industry
Industry Median: 4.09
vs NSE:APRAMEYA: 7.64
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aprameya Engineering Return-on-Tangible-Equity Related Terms
Aprameya Engineering Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.64% mean?
Aprameya Engineering (NSE:APRAMEYA) has a Return-on-Tangible-Equity of 7.64% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aprameya Engineering and its competitors. This is 64% below median its historical median of 21.28. Over the past decade, Aprameya Engineering's Return-on-Tangible-Equity has ranged from 7.64 to 176.15. According to the industry distribution chart, Aprameya Engineering ranks #309 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 40.8%.
Is Aprameya Engineering's Return-on-Tangible-Equity too high?
Aprameya Engineering's current Return-on-Tangible-Equity of 7.64% is 64% below median its 10-year median of 21.28. Over the past 10 years, this metric has ranged from a low of 7.64 to a high of 176.15. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.09. Aprameya Engineering's value of 7.64% is 86.8% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #309 out of 757 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #309 out of 757 companies for Return-on-Tangible-Equity. This puts Aprameya Engineering in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.09. Aprameya Engineering's value of 7.64% is 86.8% above this benchmark. Historically, Aprameya Engineering's own Return-on-Tangible-Equity has ranged from 7.64 to 176.15 over the past decade. While the company's 10-year median is 21.28 vs. the industry median of 4.09, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.09, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current Return-on-Tangible-Equity of 7.64% is 86.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current Return-on-Tangible-Equity is 7.64%, which is 64% below median its own 10-year median of 21.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current Return-on-Tangible-Equity of 7.64%. The current Return-on-Tangible-Equity is 7.64%, which is 64% below median its 10-year median of 21.28 and 86.8% above the Medical Devices & Instruments industry median of 4.09. Aprameya Engineering's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current Return-on-Tangible-Equity is 7.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
42GF Score
Get the complete analysis for NSE:APRAMEYA
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 